Clinical Trial Information

A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PLN-74809 (Bexotegrast) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON)

Protocol Number: 16713
Status: Open
Age Group: Adult
Treatment Type: Treatment
Secondary Protocol No.: PLN-74809-IPF-202
Phase: II
NCT ID: NCT04396756

Scope Information

Scope:: National
Disease Site(s):: Other